The portfolio solidly beat its primary and secondary benchmarks, the MSCI EAFE Index and MSCI AC World ex USA Index, in Q1.

Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...

Makary previously said in an April 17 interview with Megyn Kelly that there "were not cuts to scientists, or reviewers, or inspectors. Absolutely none." (Tin, 4/23) A Whole Foods Market in the South ...